ResearcherWuhan UniversityActive in the last 2 years
Yufeng Yuan
Matched on ORCID iD 0000-0003-3924-3803; OpenAlex author ID A5014384556. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers
Papers 6
- Improved Predictability of Diagnosis and Prognosis Using Serum- and Tissue-Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenoc… Last author DOI 10.1002/cam4.70538↗
- Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41419-025-07720-y↗
- Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the… Last author DOI 10.1021/acsnano.3c07002↗
- A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma. Last author DOI 10.1155/2022/8909631↗
- Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fonc.2022.837560↗
- Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2. Co-author DOI 10.1111/jcmm.14766↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ming Tian · 3 shared papers, 2024–2025 · strength 0.65
- Paper Improved Predictability of Diagnosis and Prognosis Using Serum- and Tissue-Derived Extracellular Vesicles From Bulk mRN… DOI 10.1002/cam4.70538↗
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002↗
- Peng Xia · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002↗
- Chengming Qu · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002↗
- Zhiyong Yang · 2 shared papers, 2020–2025 · strength 0.38
- Paper Improved Predictability of Diagnosis and Prognosis Using Serum- and Tissue-Derived Extracellular Vesicles From Bulk mRN… DOI 10.1002/cam4.70538↗
- Paper Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in … DOI 10.1111/jcmm.14766↗
- Qian Zhu · 2 shared papers, 2022 · strength 0.34
- Qian Zhu · 1 shared paper, 2025 · strength 0.26
- Tianyin Ma · 1 shared paper, 2025 · strength 0.21
- Jie Liu · 1 shared paper, 2025 · strength 0.21
- Xiao Zhang · 1 shared paper, 2022 · strength 0.20
- Tengxiang Chen · 1 shared paper, 2024 · strength 0.18
- Zhiyong Yang · 1 shared paper, 2024 · strength 0.18
- Guoliang Qiao · 1 shared paper, 2022 · strength 0.14
- Dan Shang · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.